Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Prevotella copri, Indole-3-Pyruvic Acid, and Breast Cancer P
2026-07-14
This study reveals that enrichment of Prevotella copri in the gut microbiota of breast cancer patients depletes host indole-3-pyruvic acid (IPyA), a metabolite with intrinsic anti-tumor properties. Mechanistically, this microbial shift inactivates the AMPK pathway via UHRF1-mediated regulation, thereby promoting tumor growth and altering host metabolic signaling.
-
CD47 Blocks Phagocytosis via Vav Dephosphorylation and Rac1
2026-07-14
This study defines the molecular mechanism by which CD47 on cell surfaces inhibits macrophage-mediated phagocytosis, focusing on the dephosphorylation of the guanine nucleotide exchange factor Vav and subsequent suppression of Rac1 activation. These findings illuminate a critical immune evasion pathway and suggest precise intervention points for cancer immunotherapy.
-
Wortmannin: Expanding PI3K Inhibitor Utility in Antiviral Re
2026-07-13
Explore Wortmannin's role as a PI3K inhibitor in not only cancer pathways but also antiviral applications, with a deep dive into mechanistic insights and guidance for experimental design. This article uniquely connects advanced PI3K signaling research to viral entry inhibition, including practical assay recommendations.
-
Pioglitazone as a PPARγ Agonist: Applied Workflows & Insight
2026-07-13
Pioglitazone, a selective PPARγ agonist, is transforming how researchers dissect metabolic and immune signaling pathways in models spanning diabetes, neurodegeneration, and inflammation. This article bridges protocol strategies, recent breakthroughs, and troubleshooting wisdom to empower robust and reproducible results in diverse experimental settings.
-
Resazurin Sodium Salt: Precision for Translational Cell Viab
2026-07-12
Resazurin sodium salt, a fluorogenic oxidation-reduction indicator, is redefining cell viability and cytotoxicity assessment across translational research. This article delivers mechanistic insight and strategic guidance—bridging metabolic disease modeling, high-throughput screening, and cancer research—while positioning APExBIO's offering as the gold standard for robust, reproducible results.
-
Norovirus Exploits NINJ1 for Selective Viral Protein Secreti
2026-07-10
This study reveals that murine norovirus hijacks the plasma membrane protein NINJ1 to selectively secrete its NS1 protein, uncovering a previously uncharacterized pathway for unconventional viral protein export. The findings illuminate novel host-pathogen interactions and provide new perspectives on regulated cell death and secretion mechanisms.
-
Mestranol-Induced Reversible Lysosomal Stress in Zebrafish M
2026-07-09
This study demonstrates that mestranol, a synthetic estrogen, induces a reversible lysosomal storage–like state in zebrafish microglia without affecting apoptosis or cell number. The findings introduce a tractable in vivo model for probing environmental estrogen impact on microglial lysosomal function and neuroimmunotoxicity.
-
High-Throughput BBB Model: Integrating MDR1 Cells and Lysoso
2026-07-09
This study establishes a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, incorporating lysosomal trapping correction to enhance prediction of CNS drug permeability. The model demonstrates robust correlation with in vivo brain distribution, offering a cost- and time-efficient tool for early-stage neurological drug screening.
-
FLAG tag Peptide (DYKDDDDK): Single-Molecule Precision in Pr
2026-07-08
Explore the FLAG tag Peptide (DYKDDDDK) as a precision tool for single-molecule protein detection and imaging. This article uniquely connects advanced antibody screening innovations with practical assay design, optimizing the value of epitope tags in recombinant protein research.
-
Annexin V-Cy5 Apoptosis Kit: Benchmarking Apoptosis Detectio
2026-07-08
The Annexin V-Cy5 Apoptosis Kit enables rapid, high-sensitivity detection of apoptosis via phosphatidylserine binding. This article details the biological rationale, mechanism of action, and evidence for its use in neuroimmune and cancer research. Common misconceptions and optimal integration in microglial workflows are also addressed.
-
4-Hydroxytamoxifen: Technical Parameters for Cancer Research
2026-07-07
4-Hydroxytamoxifen (SKU B6167) addresses the need for a high-purity, DMSO-soluble estrogen receptor modulator in breast and prostate cancer research, as well as cardiac myocyte studies. It should not be used in protocols requiring ethanol or aqueous solubility, and careful storage and handling are critical to ensure reproducibility.
-
InstaBlue Protein Stain Solution: Elevating Protein Visualiz
2026-07-07
Discover how InstaBlue Protein Stain Solution transforms Coomassie Brilliant Blue protein staining with unmatched speed, sensitivity, and compatibility for advanced biomedical research. This article explores the science, workflow advantages, and decision-making insights for optimal protein electrophoresis analysis.
-
Mestranol Triggers Reversible Lysosomal Stress in Zebrafish
2026-07-06
This study demonstrates that mestranol, a synthetic estrogen, induces a reversible lysosomal storage–like state in zebrafish microglia, impairing intracellular digestion without increasing apoptosis. The work establishes a live, pharmacologically-inducible model for studying environmental estrogen impacts on microglial lysosomal homeostasis and neuroimmune vulnerability.
-
Golgi-Tracker Green: Optimized Live-Cell Golgi Imaging Workf
2026-07-06
Golgi-Tracker Green delivers superior specificity and photostability for live-cell Golgi apparatus labeling, outperforming conventional probes in dynamic studies of lipid transport and sphingolipid metabolism. Discover advanced protocols, troubleshooting insights, and translational use-cases that set APExBIO’s probe apart for high-impact cell biology and oncology research.
-
CBD Attenuates Orofacial Pain via Endocannabinoid and Seroto
2026-07-05
This study demonstrates that cannabidiol (CBD) alleviates both sensory and affective components of orofacial inflammatory pain in mice by targeting endocannabinoid and serotonergic pathways. The work advances understanding of multidimensional pain modulation and highlights translational opportunities for treating complex pain syndromes.